These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23715170)

  • 1. Effect of common single-nucleotide polymorphisms in acetylsalicylic acid metabolic pathway genes on platelet reactivity in patients with diabetes.
    Postula M; Janicki PK; Rosiak M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G
    Med Sci Monit; 2013 May; 19():394-408. PubMed ID: 23715170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of common single nucleotide polymorphisms in leukotriene pathway genes on platelet reactivity in patients with diabetes.
    Rosiak M; Postula M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Zaremba M; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G; Janicki PK
    Mol Med Rep; 2013 Sep; 8(3):853-60. PubMed ID: 23828562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes.
    Postula M; Kaplon-Cieslicka A; Rosiak M; Kondracka A; Serafin A; Filipiak KJ; Czlonkowski A; Opolski G; Janicki PK
    J Thromb Haemost; 2011 Nov; 9(11):2291-301. PubMed ID: 21854539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation re-sequencing of genes involved in increased platelet reactivity in diabetic patients on acetylsalicylic acid.
    Postula M; Janicki PK; Eyileten C; Rosiak M; Kaplon-Cieslicka A; Sugino S; Wilimski R; Kosior DA; Opolski G; Filipiak KJ; Mirowska-Guzel D
    Platelets; 2016 Jun; 27(4):357-64. PubMed ID: 26599574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
    Postula M; Janicki PK; Rosiak M; Przybylkowski A; Kaplon-Cieslicka A; Grygorowicz T; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G
    Cardiol J; 2013; 20(2):170-7. PubMed ID: 23558875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New single-nucleotide polymorphisms associated with differences in platelet reactivity and their influence on survival in patients with type 2 diabetes treated with acetylsalicylic acid: an observational study.
    Milanowski L; Pordzik J; Janicki PK; Kaplon-Cieslicka A; Rosiak M; Peller M; Tyminska A; Ozieranski K; Filipiak KJ; Opolski G; Mirowska-Guzel D; Postula M
    Acta Diabetol; 2017 Apr; 54(4):343-351. PubMed ID: 27995340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy.
    Postula M; Janicki PK; Rosiak M; Kaplon-Cieslicka A; Trzepla E; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G
    J Thromb Thrombolysis; 2013 Jul; 36(1):65-73. PubMed ID: 23054467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
    Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
    Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Brain-Derived Neurotrophic Factor is Related to Platelet Reactivity but not to Genetic Polymorphisms within BDNF Encoding Gene in Patients with Type 2 Diabetes.
    Eyileten C; Zaremba M; Janicki PK; Rosiak M; Cudna A; Kapłon-Cieślicka A; Opolski G; Filipiak KJ; Kosior DA; Mirowska-Guzel D; Postula M
    Med Sci Monit; 2016 Jan; 22():69-76. PubMed ID: 26739449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of doubling the dose of acetylsalicylic acid (ASA) on platelet function parameters in patients with type 2 diabetes and platelet hyperreactivity during treatment with 75 mg of ASA: a subanalysis of the AVOCADO study.
    Rosiak M; Postuła M; Kapłon-Cieślicka A; Trzepla E; Filipiak KJ; Członkowski A; Opolski G
    Kardiol Pol; 2013; 71(6):552-7. PubMed ID: 23797426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of common single nucleotide polymorphisms in COX-1 gene on related metabolic activity in diabetic patients treated with acetylsalicylic acid.
    Postula M; Janicki PK; Rosiak M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G
    Arch Med Sci; 2014 Dec; 10(6):1198-205. PubMed ID: 25624859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplate
    Roullet S; Labrouche S; Carrie C; Auque H; Berard X; Freyburger G
    J Thromb Haemost; 2018 Mar; 16(3):583-591. PubMed ID: 29314596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.
    Watala C; Pluta J; Golanski J; Rozalski M; Czyz M; Trojanowski Z; Drzewoski J
    J Mol Med (Berl); 2005 Feb; 83(2):148-58. PubMed ID: 15723265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do statins influence platelet reactivity on acetylsalicylic acid therapy in patients with type 2 diabetes?
    Postula M; Rosiak M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G
    Cardiol J; 2012; 19(5):494-500. PubMed ID: 23042313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study.
    Rosiak M; Postula M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Czlonkowski A; Janicki PK; Filipiak KJ; Opolski G
    Cardiol J; 2013; 20(5):545-51. PubMed ID: 24469880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of platelet function using PFA-100® in patients treated with Acetylsalicylic acid and qualified for Trauma and Orthopedic surgery procedures.
    Kurak J; Zając P; Czyżewski D; Kucharski R; Grzanka R; Kasperska-Zajac A; Koczy B
    Platelets; 2016 Nov; 27(7):680-686. PubMed ID: 27094089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus.
    Gurbel PA; Bliden KP; Chaudhary R; Patrick J; Liu F; Chen G; McLeod C; Tantry US
    Am J Cardiol; 2016 Dec; 118(12):1941-1947. PubMed ID: 27769511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
    Zhang D; Zhang X; Liu D; Liu T; Cai W; Yan C; Han Y
    Cardiovasc Diabetol; 2016 Mar; 15():50. PubMed ID: 27005817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.
    Valles J; Santos MT; Aznar J; Osa A; Lago A; Cosin J; Sanchez E; Broekman MJ; Marcus AJ
    Circulation; 1998 Feb; 97(4):350-5. PubMed ID: 9468208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.